Clinical & Experimental Therapeutics
The completion of a Pharm.D., D.D.S., D.V.M. or other professional health degree is required for admission into this training track.
The focus of the program is translational research, which involves studies that occur at the interface of the bench and bedside. Information flow at this interface is bi-directional. Hence, PhD graduates of the Clinical & Experimental Therapeutics program will be trained to function at this interface. Since all students admitted to the program will have a clinical/health profession degree, the emphasis of the program will be training in the basic science, which improves the graduate's ability to successfully compete for extramural funding. There are required clinical components to assure competency in the foundations, principles and processes of clinical research. The keystone of the training is the conduct of an integrated laboratory-based and clinical dissertation.
Several graduate programs in The University of Kentucky recently received financial support from the Research Challenge Initiative, a Commonwealth of Kentucky supported effort to enable The University of Kentucky to become a top 20 federal research institution by the year 2020. The Clinical and Experimental Therapeutics training program supports graduate students with stipends, payment of tuition, as well as health insurance. The financial support comes from the Research Challenge Initiative and from teaching assistant assignments. Even higher stipends are available when an extramural/competitive fellowship is received, such as an AFPE fellowship or an NIH National Research Service Award.
The Clinical & Experimental Therapeutics faculty have diverse areas of expertise; collectively, there are therapeutic strengths in Oncology, Cardiology, Infectious Disease, and Neurosciences. Following are the graduate faculty in the Clinical and Experimental Therapeutics training program.
- Val R. Adams, Pharm.D.
- Björn Bauer, Ph.D.
- Penni Black, Ph.D.
- David S. Burgess, Pharm.D., FCCP
- Linda P. Dwoskin, Ph.D.
- David Feola, Pharm.D., Ph.D.
- Gregory Graf, Ph.D.
- Jimmi C. Hatton, Pharm.D.
- Markos Leggas, Ph.D.
- Charles D. Loftin, Ph.D.
- Patrick J. McNamara, Ph.D.
- James Pauly, Ph.D.
- Vincent Venditto , Ph.D.
- Daniel P. Wermeling, Pharm.D.